Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2026-06-05 @ 5:18 PM
Study NCT ID:
NCT01473420
Status:
COMPLETED
Last Update Posted:
2018-08-09
First Post:
2011-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin
Sponsor:
Organization: